Welcome to Infinite Health! In this episode, Dr. Maran to cut through the hype and confusion surrounding peptides, the molecules taking the wellness world by storm. From celebrities and influencers touting miraculous results to a booming marketplace flooded with questionable products, it’s tough to know what’s safe, what’s science-backed, and what’s just clever marketing.
Together, Dr. Maran break down what peptides really are, which ones have robust clinical research to support their use, and which ones are being sold on little more than risky speculation. They explore how influencer culture and regulatory shifts have created both opportunities and dangers for consumers. You’ll hear about the promise, the red flags, and most importantly, get a clear framework to help you evaluate any health claim about peptides, so you can make informed decisions rooted in real evidence, not just the latest trend.
00:00 Explaining peptides and their role
04:23 Concerns about peptide therapy evidence
07:53 Pharma patents and peptide trials
12:01 Issues with TB500 research integrity
14:39 Russian clinical use of peptides
18:29 Discussing placebo effects in studies
23:08 Discussing FDA and compounding pharmacies
24:11 Access to medical treatments debate
28:01 Questions to ask before taking supplements
32:15 Skepticism in pharmaceutical research
34:26 Understanding peptides and their risks
Peptides: Promise, Hype, and the Importance of Evidence Insights from Infinite Health
In the latest episode of Infinite Health, host Dr. Arasi Maran to untangle the web of fact and fiction around peptides, one of the most buzzed-about topics in modern wellness. With headlines featuring household names like Joe Rogan, political lobbying by RFK Jr., and wellness clinics charging thousands for peptide therapies, it’s no wonder confusion and hype runs rampant. This episode cuts through the noise and delivers what every informed consumer needs: an evidence-based framework for evaluating peptide claims.
What Are Peptides?
The episode begins at square one: “What is a peptide?” Dr. Arasi Maran clarifies that peptides are not fringe science. Insulin, oxytocin, and blockbuster drugs like Ozempic are all peptides, rigorously tested and FDA-approved (01:15). In fact, the FDA has approved over 100 peptide-based drugs; these molecules, made up of short chains of amino acids, act as the body’s internal messaging system, instructing cells to grow, repair, and regulate crucial processes.
Yet, Dr. Arasi Maran stresses, just because some peptides are well-studied and safe, it does not mean all peptides are created equal. The leap the wellness industry makes “peptides work, so this new peptide must work too” is both misleading and dangerous (03:50).
The Gold Standard vs. The Wild West
Evidence is everything. Dr. Arasi Maran outlines the arduous process of developing FDA-approved peptides, which includes years of clinical trials, replication, side effect monitoring, and billions of dollars of investment (07:07). Drugs like insulin, semaglutide (Ozempic), and oxytocin have been studied in thousands sometimes millions of people.
Contrast this with the so-called “Wolverine stack” peptides like BPC-157 and TB-500 touted by celebrity influencers for rapid recovery. The science behind these compounds is shockingly sparse: as of 2020, just three tiny, uncontrolled human studies on BPC-157 (fewer than 30 participants in total), all from the same lab (09:25). For TB-500, there are literally zero published human trials (12:36). That’s the entirety of the human evidence base for these widely sold injections.
Safety Isn’t Just Theoretical
Why does this matter? Because untested peptides can have unknown risks. Some rodent studies seem promising, but only 5–10% of findings in animals translate safely to humans (11:01). Cancelled, unpublished safety trials are major red flags. Yet, the influencer ecosystem and biohacking forums present these peptides as life-changing, drawing people into gray market supply chains with little to no oversight.
Regulation, Controversy, and the FDA
The breakdown of regulatory oversight is a central theme (20:22). In 2023, the FDA moved to restrict many popular peptides, citing insufficient data and contamination risks. This well-intended action drove even more consumers to seek out unregulated, lower-quality products from international suppliers.
Matters became even murkier in 2026, as RFK Jr. announced (on a podcast, not through official channels) the reclassification of many peptides shifting them back into legal gray zones for compounding pharmacies. Dr. Arasi Maran draws a sharp contrast between the claims of insufficient evidence for vaccines (studied in hundreds of millions) versus the green-lighting of peptides with near-zero human data.
A Framework for Skepticism
How can listeners protect themselves in this landscape? Dr. Arasi Maran offers a clear decision framework (28:01):
Define your goal: What are you actually trying to address?
Examine the evidence: How extensive is the human research? Are there published clinical trials? Is the safety profile understood?
Exercise healthy skepticism: Ask whether benefits outweigh risks, and seek out both positive and negative data.
Delay unproven interventions: If robust evidence doesn’t exist, wait until it does your health isn’t worth gambling on hype.
The Bottom Line
Peptides aren’t all snake oil or panacea. Some have decades of documentation, others are high-risk experiments masquerading as wellness breakthroughs. In an era where regulations are in flux and marketing often outpaces science, your sharpest advantage is the ability to separate biology from branding.
As Dr. Arasi Maran concludes: “Biology does not care who endorses something only the evidence tells the truth.” Do your homework, question the source, and don’t let the influencer machine dictate your health choices.
In short: Peptides promise a lot. Don’t take that promise at face value. Demand proof and only then, decide.